logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Class
    3. alpha-Adrenergic Blocker

    alpha-Adrenergic Blocker class drugs

    FiltersReset Filters
    16 results
    • alfuzosin hydrochloride

      (Alfuzosin Hydrochloride)
      Rising Pharma Holdings, Inc.
      Usage: Alfuzosin hydrochloride extended-release tablets are indicated for treating signs and symptoms of benign prostatic hyperplasia. They are not intended for hypertension treatment or pediatric use.
    • cardura

      (doxazosin mesylate)
      ROERIG
      Usage: CARDURA is indicated for the treatment of benign prostatic hyperplasia (BPH) and hypertension. It helps alleviate BPH symptoms and lowers blood pressure, reducing the risk of cardiovascular events like strokes and heart attacks, and can be used alone or with other antihypertensive medications.
    • cardura

      (doxazosin)
      Viatris Specialty LLC
      Usage: CARDURA is indicated for the treatment of Benign Prostatic Hyperplasia (BPH) and hypertension. It helps alleviate symptoms of BPH and lowers blood pressure, thereby reducing the risk of fatal and nonfatal cardiovascular events, including strokes and myocardial infarctions. It can be used alone or with other antihypertensives.
    • carvedilol

      (Carvedilol)
      Quallent Pharmaceuticals Health LLC
      Usage: Carvedilol is indicated for treating mild-to-severe chronic heart failure, reducing cardiovascular mortality in stable patients post-myocardial infarction with left ventricular dysfunction, and managing essential hypertension, either alone or with other antihypertensives, particularly thiazide-type diuretics.
    • carvedilol

      (Carvedilol)
      Zydus Pharmaceuticals USA Inc.
      Usage: Carvedilol is indicated for treating mild-to-severe chronic heart failure, reducing cardiovascular mortality in patients with left ventricular dysfunction post-myocardial infarction, and managing essential hypertension, either alone or with other antihypertensive agents.
    • carvedilol

      (CARVEDILOL)
      Advagen Pharma Ltd
      Usage: Carvedilol is indicated for treating chronic heart failure, reducing cardiovascular mortality in patients post-myocardial infarction with left ventricular dysfunction, and managing essential hypertension, either alone or with other antihypertensive agents.
    • carvedilol

      (Carvedilol)
      Bayshore Pharmaceuticals LLC
      Usage: Carvedilol Tablets are indicated for the treatment of chronic heart failure, left ventricular dysfunction following myocardial infarction, and management of essential hypertension. It is used to improve survival, reduce hospitalization risk, and can be combined with other antihypertensive agents.
    • carvedilol

      (Carvedilol)
      Zydus Lifesciences Limited
    • carvedilol phosphate

      (Carvedilol Phosphate)
      Sun Pharmaceutical Industries, Inc.
      Usage: Carvedilol phosphate extended-release capsules are indicated for treating mild-to-severe chronic heart failure, reducing cardiovascular mortality in stable patients post-myocardial infarction with left ventricular dysfunction, and managing essential hypertension, either alone or alongside other antihypertensive medications.
    • carvedilol phosphate

      (Carvedilol Phosphate)
      NorthStar RxLLC
      Usage: Carvedilol phosphate extended-release capsules are indicated for treating mild-to-severe chronic heart failure, reducing cardiovascular mortality in post-myocardial infarction patients with left ventricular dysfunction, and managing essential hypertension, either alone or with other antihypertensive agents.